Ozempic Reduces Cardiac Risks in Diabetes Patients
Favicon 
www.newsmax.com

Ozempic Reduces Cardiac Risks in Diabetes Patients

Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients‚ a large late-stage study found‚ cutting the risk of major cardiac events and death by 24%. Around 40% of people with Type 2 diabetes have chronic kidney...